Research graph
References from Diagnosis and Management of Adult Type 1 Diabetes Mellitus: Systematic Reviews of Biomarkers, Insulin Regimens and Insulin Delivery Devices Highlighting Evidence Gaps in Emergency and Humanitarian Settings. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1016/s0140‐6736(23)00223‐4
10.1016/s0140‐6736(23)00223‐4 · External reference
10.1007/s00125‐021‐05568‐3
10.1007/s00125‐021‐05568‐3 · External reference
10.1016/j.jcjd.2017.10.012
10.1016/j.jcjd.2017.10.012 · External reference
10.1186/s13031‐024‐00631‐3
10.1186/s13031‐024‐00631‐3 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
10.2337/ds18‐0070
10.2337/ds18‐0070 · External reference
10.1016/j.ecl.2023.05.010
10.1016/j.ecl.2023.05.010 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews
10.1136/bmj.n71 · 2021 · External reference
PRESS Peer Review of Electronic Search Strategies: 2015 Guideline Statement
10.1016/j.jclinepi.2016.01.021 · 2016 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
2021 · External reference
Unresolved reference
External reference
10.1136/bmj.i4919
10.1136/bmj.i4919 · External reference
AMSTAR 2: A Critical Appraisal Tool for Systematic Reviews That Include Randomised or Non‐Randomised Studies of Healthcare Interventions, or Both
10.1136/bmj.j4008 · 2017 · External reference
10.7326/0003‐4819‐155‐8‐201110180‐00009
10.7326/0003‐4819‐155‐8‐201110180‐00009 · External reference
Unresolved reference
2021 · External reference
Unresolved reference
External reference
10.1016/j.jclinepi.2011.06.004
10.1016/j.jclinepi.2011.06.004 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
10.1046/j.1523‐1755.2000.00335.x
10.1046/j.1523‐1755.2000.00335.x · External reference
10.1016/j.cca.2017.12.043
10.1016/j.cca.2017.12.043 · External reference
10.3109/00365518609083728
10.3109/00365518609083728 · External reference
10.1093/jalm/jfab141
10.1093/jalm/jfab141 · External reference
10.5114/fmpcr.2023.125487
10.5114/fmpcr.2023.125487 · External reference
Classification of Newly‐Onset IDDIM and NIDDIM in Subjects Aged 25‐45 Years in Sudan
1998 · External reference
10.1016/j.clinthera.2024.07.002
10.1016/j.clinthera.2024.07.002 · External reference
10.1136/bmjopen‐2019‐031586
10.1136/bmjopen‐2019‐031586 · External reference
10.2337/diacare.27.8.1936
10.2337/diacare.27.8.1936 · External reference
10.1507/endocrj.ej22‐0146
10.1507/endocrj.ej22‐0146 · External reference
10.1007/s00125‐021‐05492‐6
10.1007/s00125‐021‐05492‐6 · External reference
10.1016/j.diabres.2004.05.004
10.1016/j.diabres.2004.05.004 · External reference
10.1007/s13410‐018‐0637‐y
10.1007/s13410‐018‐0637‐y · External reference
10.1155/2019/1747684
10.1155/2019/1747684 · External reference
10.1007/s11695‐017‐2804‐5
10.1007/s11695‐017‐2804‐5 · External reference
10.1002/9781119756194.ch9
10.1002/9781119756194.ch9 · 2023 · External reference
10.1136/bmj.304.6818.19
10.1136/bmj.304.6818.19 · External reference
10.1038/ki.1992.140
10.1038/ki.1992.140 · External reference
10.1001/archopht.1988.01060140402041
10.1001/archopht.1988.01060140402041 · External reference
Clinical Experience With NovoPen II and Insulin Protaphane HM Penfill
1988 · External reference
10.1111/j.1464‐5491.1988.tb01054.x
10.1111/j.1464‐5491.1988.tb01054.x · External reference
10.2337/diacare.8.1.73
10.2337/diacare.8.1.73 · External reference
The Insulin Pen: A New Device for Multiple Insulin Injections
1986 · External reference
10.1002/pdi.1960070408
10.1002/pdi.1960070408 · External reference
Premixed Insulin Preparations in Pen Syringes Maintain Glycemic Control and Are Preferred by Patients
10.2337/diacare.17.8.874 · 1994 · External reference
Evaluation of Consumer Satisfaction and Quality of Life in Patients Changing to Novopen II
10.1002/pdi.1960070506 · 1990 · External reference
10.1089/dia.2009.0007
10.1089/dia.2009.0007 · External reference
10.2337/dc24‐s002
10.2337/dc24‐s002 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
10.1007/s00125‐023‐05877‐9
10.1007/s00125‐023‐05877‐9 · External reference
10.1038/s43856‐024‐00478‐y
10.1038/s43856‐024‐00478‐y · External reference
10.1371/journal.pgph.0003027
10.1371/journal.pgph.0003027 · External reference
10.1016/s2666‐7568(21)00089‐1
10.1016/s2666‐7568(21)00089‐1 · External reference
10.1007/s00125‐025‐06576‐3
10.1007/s00125‐025‐06576‐3 · External reference
10.1373/clinchem.2007.101287
10.1373/clinchem.2007.101287 · External reference
Unresolved reference
External reference
10.2337/dbi20‐0054
10.2337/dbi20‐0054 · External reference
Unresolved reference
2018 · External reference
Unresolved reference
External reference
10.1210/clinem/dgac331
10.1210/clinem/dgac331 · External reference
10.1007/s00125‐025‐06406‐6
10.1007/s00125‐025‐06406‐6 · External reference
10.26719/2025.31.4.268
10.26719/2025.31.4.268 · External reference
Unresolved reference
External reference
10.17925/ee.2018.14.1.47
10.17925/ee.2018.14.1.47 · External reference
Unresolved reference
External reference
10.1001/jamanetworkopen.2024.3474
10.1001/jamanetworkopen.2024.3474 · External reference
10.1136/bmjgh‐2019‐001410
10.1136/bmjgh‐2019‐001410 · External reference
